TWI734046B - 包含替米沙坦或其藥學上可接受鹽類之具有改良的吸濕性質和溶解速率之製劑 - Google Patents
包含替米沙坦或其藥學上可接受鹽類之具有改良的吸濕性質和溶解速率之製劑 Download PDFInfo
- Publication number
- TWI734046B TWI734046B TW107139601A TW107139601A TWI734046B TW I734046 B TWI734046 B TW I734046B TW 107139601 A TW107139601 A TW 107139601A TW 107139601 A TW107139601 A TW 107139601A TW I734046 B TWI734046 B TW I734046B
- Authority
- TW
- Taiwan
- Prior art keywords
- telmisartan
- pharmaceutically acceptable
- acceptable salt
- tablet
- amlodipine
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
??10-2017-0152226 | 2017-11-15 | ||
KR1020170152226A KR102066832B1 (ko) | 2017-11-15 | 2017-11-15 | 텔미사르탄 또는 그의 약제학적으로 허용가능한 염을 포함하는 인습성 및 용출률이 향상된 제제 |
KR10-2017-0152226 | 2017-11-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201922242A TW201922242A (zh) | 2019-06-16 |
TWI734046B true TWI734046B (zh) | 2021-07-21 |
Family
ID=66539176
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW107139601A TWI734046B (zh) | 2017-11-15 | 2018-11-08 | 包含替米沙坦或其藥學上可接受鹽類之具有改良的吸濕性質和溶解速率之製劑 |
TW109108987A TW202026000A (zh) | 2017-11-15 | 2018-11-08 | 包含替米沙坦或其藥學上可接受鹽類之具有改良的吸濕性質和溶解速率之製劑 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW109108987A TW202026000A (zh) | 2017-11-15 | 2018-11-08 | 包含替米沙坦或其藥學上可接受鹽類之具有改良的吸濕性質和溶解速率之製劑 |
Country Status (6)
Country | Link |
---|---|
KR (1) | KR102066832B1 (ko) |
MY (1) | MY196892A (ko) |
PH (1) | PH12020550597A1 (ko) |
SG (1) | SG11202001460TA (ko) |
TW (2) | TWI734046B (ko) |
WO (1) | WO2019098540A1 (ko) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017048033A1 (en) * | 2015-09-15 | 2017-03-23 | Chong Kun Dang Pharmaceutical Corp. | Pharmaceutical combination preparation |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101010325B1 (ko) * | 2009-12-17 | 2011-01-25 | 현대약품 주식회사 | 텔미사르탄 및 히드로클로로티아지드를 함유하는 약제학적 조성물 |
WO2011149438A1 (en) * | 2010-05-28 | 2011-12-01 | Mahmut Bilgic | Combination of antihypertensive agents |
KR20150111686A (ko) * | 2014-03-26 | 2015-10-06 | 주식회사 종근당 | 산화안정성이 향상된 텔미사르탄 및 (s)-암로디핀을 포함하는 약제학적 제제 |
KR101823071B1 (ko) * | 2016-02-15 | 2018-01-29 | 한림제약(주) | 텔미사르탄-함유 정제의 제조방법 |
-
2017
- 2017-11-15 KR KR1020170152226A patent/KR102066832B1/ko active IP Right Grant
-
2018
- 2018-10-16 MY MYPI2020001765A patent/MY196892A/en unknown
- 2018-10-16 SG SG11202001460TA patent/SG11202001460TA/en unknown
- 2018-10-16 WO PCT/KR2018/012191 patent/WO2019098540A1/en active Application Filing
- 2018-11-08 TW TW107139601A patent/TWI734046B/zh active
- 2018-11-08 TW TW109108987A patent/TW202026000A/zh unknown
-
2020
- 2020-04-30 PH PH12020550597A patent/PH12020550597A1/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017048033A1 (en) * | 2015-09-15 | 2017-03-23 | Chong Kun Dang Pharmaceutical Corp. | Pharmaceutical combination preparation |
Also Published As
Publication number | Publication date |
---|---|
MY196892A (en) | 2023-05-09 |
PH12020550597A1 (en) | 2021-02-15 |
KR20190055471A (ko) | 2019-05-23 |
TW201922242A (zh) | 2019-06-16 |
SG11202001460TA (en) | 2020-03-30 |
KR102066832B1 (ko) | 2020-01-16 |
WO2019098540A1 (en) | 2019-05-23 |
TW202026000A (zh) | 2020-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005300787B2 (en) | Bilayer tablet comprising telmisartan and amlodipine | |
AU2007297333B2 (en) | Solid dosage form of olmesartan medoxomil and amlodipine | |
MX2011006009A (es) | Composicion farmaceutica solida que comprende amlodipina y losartan y procesos para producir la misma. | |
PT1448235E (pt) | Composições farmacêuticas orais de libertação controlada de 5,8,14-triazatetraciclo ( 10.3.1.0(2,11).0(4,9) ) - hexadeca-2(11),3,5,7,9-pentaeno. | |
JP6068765B2 (ja) | 薬学的複合製剤 | |
JP2009527477A (ja) | 低紅潮ナイアシン製剤 | |
JP6231959B2 (ja) | カルシウム拮抗薬/アンジオテンシンii受容体拮抗薬含有医薬製剤 | |
KR20180044873A (ko) | 암로디핀, 로자탄 및 로수바스타틴을 포함하는 약제학적 복합 제제 | |
JP5749247B2 (ja) | 経口用徐放性固形製剤 | |
CN108289850B (zh) | 含有氨氯地平、氯沙坦和氯噻酮的药物复合制剂 | |
WO2013100630A1 (en) | Fixed dose combination formulation comprising losartan, amlodipine and hydrochlorothiazide | |
JP6302802B2 (ja) | カルシウム拮抗薬/アンジオテンシンii受容体拮抗薬含有医薬製剤の製造方法 | |
PL236001B1 (pl) | Złożona kompozycja farmaceutyczna zawierająca kandesartan cyleksetylu oraz amlodypinę, sposób jej wytwarzania oraz jednostkowa postać dawkowania zawierająca tę kompozycję | |
JP6639368B2 (ja) | 糖尿病治療用固形製剤 | |
CA2764172A1 (en) | A thrombin receptor antagonist and clopidogrel fixed dose tablet | |
CA2882738A1 (en) | Pharmaceutical composite capsule formulation comprising irbesartan and hmg-coa reductase inhibitor | |
JP5719385B2 (ja) | ラミプリル及びベシル酸アムロジピンの固形医薬製剤及びその製造 | |
TWI681773B (zh) | 包含氨氯地平(amlodipine)及洛沙坦(losartan)之固體藥學組成物 | |
TWI734046B (zh) | 包含替米沙坦或其藥學上可接受鹽類之具有改良的吸濕性質和溶解速率之製劑 | |
SG190326A1 (en) | Complex formulation comprising lercanidipine hydrochloride and valsartan and method for the preparation thereof | |
KR101750689B1 (ko) | 약제학적 복합제제 | |
WO2024109927A1 (zh) | 包含美阿沙坦钾与钙通道阻滞剂的药物组合物,及其制备方法及应用 | |
WO2024047208A1 (en) | Anticoagulant therapy with an improved dosage regimen | |
EA029709B1 (ru) | Твердая пероральная лекарственная форма, содержащая декскетопрофен и трамадол, и способ ее изготовления | |
AU2007201830B2 (en) | High drug load tablet |